Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miguel Marco-Bonilla
Observed names:
M. Marco-Bonilla,
Miguel Marco‐Bonilla
Institutions:
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Universidad Autónoma de Madrid
Observed institutions:
Universitat de València,
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Universidad Autónoma de Madrid
ORCID:
0009-0005-5103-0327
Observed ORCID:
0009-0005-5103-0327
OpenAlex ID:
A5074974615
Dipyridamole activates adenosine A2B receptor and AMPK/cAMP signaling and promotes myogenic differentiation of myoblastic C2C12 cells
2023
·
Miguel Marco-Bonilla
, Raquel Herencia
, et al.
·
Frontiers in Pharmacology
·
18
ATP transporters in the joints
2021
·
Ane Larrañaga-Vera
, Miguel Marco-Bonilla
, et al.
·
Purinergic Signalling
·
17
PDF
Animal Models in Rheumatoid Arthritis: Is There a Correlation Between Autoantibodies in Human Pathology and Animal Models?
2025
·
Miguel Marco-Bonilla
, Maria Fresnadillo
, et al.
·
Biology
·
16
PDF
Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia
2024
·
Asunción Marín-Castejón
, Miguel Marco-Bonilla
, et al.
·
Biomedicine & Pharmacotherapy
·
11
PDF
Energy Regulation in Inflammatory Sarcopenia by the Purinergic System
2023
·
Miguel Marco-Bonilla
, Maria Fresnadillo
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Beyond joints: the importance of animal models in exploring rheumatoid arthritis comorbidities
2025
·
Miguel Marco-Bonilla
, Maria Fresnadillo
, et al.
·
Frontiers in Medicine
·
7
PDF
Dual Action of Dipyridamole in Experimental Rheumatoid Arthritis: Suppression of Joint Inflammation and Upregulation of Muscle Anabolism via Adenosine and AMPK Pathways
2025
·
Miguel Marco‐Bonilla
, Maria Fresnadillo
, et al.
·
Arthritis & Rheumatology
·
4
Impact of intra-articular high-concentration hyaluronic acid administration on the innate immune response in experimental knee osteoarthritis
2025
·
Gabriel Herrero-Beaumont
, Miguel Marco-Bonilla
, et al.
·
BMC Musculoskeletal Disorders
·
3
PDF
Persistent sarcopenia after flare remission in experimental RA responds to dipyridamole and is associated with restoration of adenosine and A2BR signaling
2026
·
Miguel Marco-Bonilla
, Maria Fresnadillo
, et al.
·
Frontiers in Pharmacology
PDF
Reply
2026
·
Miguel Marco‐Bonilla
, Aránzazu Mediero
, et al.
·
Arthritis & Rheumatology
Pos1374 Dipyridamole Prevents the Metabolic Switch Caused by Rheumatoid Arthritis in Muscle by Purinergic System Modulation
2025
·
M. Fresnadillo
, M. Marco-Bonilla
, et al.
·
Annals of the Rheumatic Diseases
Pos1413 Novel Treatment With Dipyridamole Counteracts the Sarcopenic Footprint in Experimental Ra Via Increase of Adenosine Levels and A2a/a2br Activation
2025
·
M. Marco-Bonilla
, M. Fresnadillo
, et al.
·
Annals of the Rheumatic Diseases
The activation of the purinergic system modulates the formation of foreign body giant cells in the presence of different metal alloys for clinical use
2024
·
Aránzazu Mediero
, John Jairo Aguilera-Correa
, et al.
·
Revista de Osteoporosis y Metabolismo Mineral
Pos1019 Dipyridamole, a Compound That Increases Extracellular Adenosine Levels, as a Therapeutic Agent for Rheumatoid Sarcopenia
2023
·
M. Marco-Bonilla
, M. Fresnadillo
, et al.
·
Annals of the Rheumatic Diseases
PDF
100 Activation of A2B adenosine receptor normalizes filaggrin and caspase-14 levels in a murine model of epidermal hyperplasia
2021
·
A. Marín-Castejón
, M. Marco-Bonilla
, et al.
·
Journal of Investigative Dermatology
Show more works
View as search
Works count:
15
Citation count:
85
H-index:
6
I10-index:
4
Year
Topic
Type